Home » Stocks » Divi’s Laboratories Ltd

Divi’s Laboratories Ltd

The live share price of Divi's Laboratories Ltd (DIVISLAB) as on 01 Jun 10:12am is ₹3,525.4 from NSE/BSE.

DIVISLAB NSE

₹3,525.4 ▲2.38% (81.8)

As on Jun 01, 2023 03:42 PM IST

How do you feel today about Divi's Laboratories Ltd?

Key Metrics

PE Ratio

50.63

PB Ratio

7.87

Dividend Yield

0.86%

Sector PB

4.49

Sector PE

33.46

Sector Div Yld

0.82%

Dividend Yield

Dividend per share for the most recent financial year divided by the close price

About

sec-img

Sector

Health Care

sec-img

Industry

Life Sciences Tools & Services

sec-img

Market Cap

Largecap, ₹92,325 Cr

Divi's Laboratories Limited is engaged in manufacturing and sale of active pharmaceutical ingredients (APIs) and Intermediates. Its products include Generic APIs, Intermediates, Peptide Building Blocks and Carotenoids.

The following charts display the financial performance of the Divi's Laboratories Ltd (DIVISLAB) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.

Furthermore, under the Peers section, you can find stocks that are similar to Divi's Laboratories Ltd (DIVISLAB), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.

✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.

A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.

All smallcases are created and managed by SEBI-registered investment experts.

To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.

sec-img

Sector

Health Care

sec-img

Industry

Life Sciences Tools & Services

sec-img

Market Cap

Largecap, ₹92,325 Cr

Financials

Income Statement

(INR) Y/Y Change
Revenue 8,112 Cr -10.6%
Operating Expense 5,399 Cr -3494.54%
Net Income 1,823 Cr -38.41%
Net Profit Margin 22.48% -31.11%
Earning Per Share 68 -38.4%
EBITDA 2,712 Cr -32.14%

Balance sheet

(INR) Y/Y Change
Cash & short-term Inv 2,818 Cr +30.74%
Total Assets 13,360 Cr +24.04%
Total Liabilities 1,632 Cr +10.56%
Total Equity 11,728 Cr +26.18%
Shares Outstanding 26.55 Cr +0.01%
Price to Book 9.91 -4.05%
Return on Assets 24.54% +19.36%
Return on Capital 31.42 Cr +9.44%

Cash Flows

(INR) Y/Y Change
Net Income 1,823 Cr -38.41%
Cash from Operations 1,911 Cr -1.8%
Cash from Investing -2,194 Cr -3021.5%
Cash from Financing -532 Cr +1426.05%
Net Change in Cash -815 Cr -141.04%
Free Cash Flow 1,198 Cr +15.61%
Total Promoter Holding
51.94%
Unpledged
Foreign Institutions
14.67%
Foreign Institutions
Retail & Others
12.31%
Retail & Others
Other Parties
Other Domestic Institutions
7.93%
Insurance Firms
Others
Mutual Funds
13.15%
Mutual Funds

Peers

SYNGENE

Syngene International Ltd

PE Ratio

61.49

1Y Return

▲26.64%

DCAL

Dishman Carbogen Amcis Ltd

PE Ratio

-60.45

1Y Return

▼-0.17%

VIMTALABS

Vimta Labs Ltd

PE Ratio

18.44

1Y Return

▲18.51%

Latest News

latest-news

Trade setup for Thursday: Top 15 things to know before the opening bell

19 hours ago on Moneycontrol

Change since news ▼-2.38%

Based on the OI percentage, 56 stocks were on the short-covering list. These included Balkrishna Industries, Divis Laboratories, Dabur India, Nestle India, and Britannia Industries.


latest-news

Stock market update: Stocks that hit 52-week lows on NSE

2 days ago on Economic Times

Change since news ▼-1.37%

HDFC Life, Adani Ports SEZ, Sun Pharma, Divis Labs and Dr. Reddys were among the top losers on NSE.


latest-news

Stock market update: Stocks that hit 52-week lows on NSE in today’s trade

3 days ago on Economic Times

Change since news ▼-0.32%

ONGC, Power Grid, HCL Tech, Divis Labs and Maruti Suzuki were among the top losers on NSE in today’s trade.


FAQs on Divi's Laboratories Ltd

How to buy Divi's Laboratories Ltd stocks?

You can easily buy the stocks/shares of Divi's Laboratories Ltd (DIVISLAB) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.

What is the Share Price of Divi's Laboratories Ltd?

The stock price of Divi's Laboratories Ltd as on 01 Jun 2023 is ₹3,525.4

What is the 52-week High and Low of Divi's Laboratories Ltd?

The 52-week high and low of Divi's Laboratories Ltd (DIVISLAB) is ₹3,973.9 and ₹2,730.

What is the PE and PB ratio of Divi's Laboratories Ltd?

The P/E (price-to-earnings) and P/B (price-to-book) ratios of Divi's Laboratories Ltd are 50.63 and 7.87 respectively.

What are the peers or stocks similar to Divi's Laboratories Ltd?

The peers or stocks similar to Divi's Laboratories Ltd are Syngene International Ltd, Dishman Carbogen Amcis Ltd, Vimta Labs Ltd, Vaidya Sane Ayurved Laboratories Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.

Which sector does Divi's Laboratories Ltd belong to?

Divi's Laboratories Ltd (DIVISLAB) belongs to the Labs & Life Sciences Services sector.

What is the Market Cap of Divi's Laboratories Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Divi's Laboratories Ltd (DIVISLAB) is ₹92,325 Cr as of 01 Jun 2023

Can't decide whether or not to buy Divi's Laboratories Ltd stocks? ⭐️

Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.